2011 Energy Innovation Pharmaceuticals 
Harvard Business Review
SEPTEMBER 14, 2011
We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors.
Harvard Business Review
MAY 20, 2014
The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. Consolidation of the financial sector has led to similar dynamics in other industries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
JUNE 16, 2016
The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. Innovating the Innovation Process. A National Innovation Ecosystem. The Era of Big Science.
Strategy Driven
JANUARY 24, 2011
Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.
Harvard Business Review
NOVEMBER 20, 2015
But entrepreneurial know-how and energy can work very effectively in the context of plugging-in as a supplier, as Steve Cronce and thousands of others are learning. In 2011, Havens’ collaboration with IBM procurement paid off, winning Havens four significant projects. Taking this path isn’t a cake walk, however.
Expert insights. Personalized for you.
9 
Let's personalize your content